TEAM TECHNOLOGIES ACQUISITION COMPANY – Trademark Portfolio
Entity Type: 03
TEAM TECHNOLOGIES ACQUISITION COMPANY holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include PHB, ANCHOR, FRESHCARE, and HYGIENIST CHOICE. The owner is based in MORRISTOWN, TN.
5949 COMMERCE BOULEVARD.
MORRISTOWN, TN 37814
Showing of trademarks Trademarks
Trademark Classifications
TEAM TECHNOLOGIES ACQUISITION COMPANY's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TEAM TECHNOLOGIES ACQUISITION COMPANY have?
TEAM TECHNOLOGIES ACQUISITION COMPANY has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does TEAM TECHNOLOGIES ACQUISITION COMPANY file in?
TEAM TECHNOLOGIES ACQUISITION COMPANY files trademarks across 3 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are TEAM TECHNOLOGIES ACQUISITION COMPANY's most well-known trademarks?
TEAM TECHNOLOGIES ACQUISITION COMPANY's registered trademark portfolio includes well-known marks such as PHB, ANCHOR, FRESHCARE, and HYGIENIST CHOICE. These are among 5 currently registered trademarks in the portfolio.
What is TEAM TECHNOLOGIES ACQUISITION COMPANY's trademark registration success rate?
TEAM TECHNOLOGIES ACQUISITION COMPANY has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.